Page 91 - GPD-3-3
P. 91

Gene & Protein in Disease                                              Perineural invasion in prostate cancer



            and Hochberg false discovery rate method by default were   term depression, glutamatergic synapse and leukocyte
            applied to correct the occurrence of false-positive results.   transendothelial migration were pathways upregulated
            An adjusted p < 0.05 and a logFC ≥ 1 were set as the cutoff   only in  perineural invasion-negative tumors. Chemical
            criteria. 23                                       carcinogenesis, calcium signaling pathway,  oxytocin
              The Kyoto Encyclopedia of Genes and Genomes      signaling  pathway,  transforming  growth  factor  beta
            (KEGG) is an integrated database resource for biological   (TGFβ) signaling pathway, tryptophan metabolism,
            interpretation of genome sequences and other high-  amebiasis and cardiac muscle contraction migration were
            throughput data. KEGG analyses are available at the   upregulated only in perineural invasion-positive tumors
            DAVID database (https://david.ncifcrf.gov/), a data   (Supplementary File 1 Tables S1-S4).
            resource composed of an integrated biology knowledge   The gene expression profiles of both early-  and late-
            base  and  analytic  tools  to  extract  meaningful  biological   passage human Schwann cells exposed to heregulin
            information from large quantities of genes and protein   and forskolin, contained in a GEO dataset, were used to
            collections. A p < 0.05 was set as the cutoff criterion. 24  identify DEGs with the aid of GEO2R. This online tool was
                                                               applied to compare gene expression profiles in passage 1
            2.4. Prostate cancer expression analyses           and passage 3 human Schwann cells exposed to heregulin
            Several other web resources were also used to obtain   and forskolin. Since both cell groups had been exposed
            information for prostate cancer expression studies,   to mitogens, differences in gene expression profiles
            while some others were used as analytic tools.     were interpreted as changes caused by prolonged versus
            Immunohistochemistry image-based protein data for   short-term exposure to mitogens. From this analysis, we
            both normal and cancer samples are available at the   identified a set of upregulated DEGs, which modulate
            Human Protein Atlas (https://www.proteinatlas.org/).   pathways such as neuroactive ligand-receptor interaction,
            Outputs of DNA methylation analyses were obtained from   maturity-onset diabetes of the young, and tyrosine
            MEXPRESS dataset (https://mexpress.be/?ref=labworm).   metabolism. Meanwhile, pathways that were enriched for
            The DNA methylation data in the cancer dataset (Illumina   downregulated DEGs in cancer include focal adhesion,
            Infinium Human Methylation 450 K Bead array, Illumina,   arrhythmogenic  right  ventricular  cardiomyopathy,
            USA) were classified as significant hypermethylation only   adherens junction, basal cell carcinoma, p53 signaling
            if the β value exceeded 5% of the tumors. Copy number   pathway, colorectal cancer, progesterone-mediated oocyte
            alteration analysis was performed using the cBio Cancer   maturation, oocyte meiosis, Hedgehog signaling pathway,
            Genomics Portal (http://cbioportal.org). Survival analysis   ECM-receptor interaction, melanogenesis, calcium
            of the TCGA data was performed using the survival   signaling pathway, dilated cardiomyopathy, cell cycle, and
            module of the Tumor Immune Estimation Resource     amyotrophic lateral sclerosis.
            (TIMER).  Additionally,  Kaplan–Meier  plots  were  drawn
            using TIMER to explore the association between clinical   3.2. Overview of the cancer transcriptomic analysis
            outcome  and  gene  expression,  and  to  visualize  survival   We employed a systematic and integrative approach to
            differences. 25                                    analyze cancer type-specific and Schwann cell-specific
                                                               DEGs, with the aim to construct a cancer network. We first
            3. Results                                         determined DEGs by comparing gene expression levels
            3.1. Identification of differentially expressed    between tumor and normal samples. A Venn diagram was
            genes, gene ontology enrichment, and functional    then constructed to visualize the overlap between DEG
            classification                                     genes, both upregulated and downregulated, from both
            We obtained gene expression data belonging to prostate   cancer and Schwann cells. Among the upregulated genes
            adenocarcinoma specimens from TCGA; these data were   from perineural invasion-negative and -positive samples,
            preprocessed using standard methods. We performed   we identified 166 and 142 DEGs, respectively, that were
            a DEG analysis using data obtained from patients with   coexpressed in Schwann cells.
            perineural invasion-positive and  -negative prostate   We also performed a KEGG analysis to investigate
            adenocarcinoma. According to DAVID analysis, cell   pathways  with  major  expression changes  in  Schwann
            adhesion molecules (CAMs), pathways in cancer,     cell lines and perineural invasion-negative or  -positive
            melanogenesis,  gap  junction,  Circadian  entrainment,  Fc   tumors, based on previously identified upregulated
            gamma R-mediated phagocytosis, gastric acid secretion,   DEGs. The analysis revealed that microRNAs in cancer,
            axon guidance, histidine metabolism, viral myocarditis,   complement and coagulation cascades, Hippo signaling
            serotonergic synapse, small cell lung cancer, long-  pathway and transcriptional misregulation in cancer were


            Volume 3 Issue 3 (2024)                         3                               doi: 10.36922/gpd.3146
   86   87   88   89   90   91   92   93   94   95   96